Jason P. Hunt

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic”.

Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic

Journal of Behavioral Medicine(2024)10.1007/s10865-023-00465-z

N/A

0.251DataRank · unranked

3 citations

Jennifer Ose, Cassandra A. Hathaway, Laura B. Oswald, Sheetal Hardikar, Caroline Himbert +36 more

Factors associated with changes in exercise behaviors during the COVID-19 pandemic

Cancer Causes & Control(2022)10.1007/s10552-022-01580-z

N/A

0DataRank · unranked

10 citations

Cassandra A. Hathaway, Bailee Daniels, Karen Salas, Anjelica Ashworth, Biljana Gigic +30 more

The association between adverse childhood experiences and treatment response for adults with alcohol and other drug use disorders

American Journal on Addictions(2022)10.1111/ajad.13366

N/A

0DataRank · unranked

9 citations

Deborah Morrison, Jillian M. Rung, Jason P. Hunt, Scott Teitelbaum, Lisa J. Merlo +1 more

Pain Predicts Dropout From Substance Use Treatment

Journal of Studies on Alcohol and Drugs(2024)10.15288/jsad.23-00099

N/A

0DataRank · unranked

4 citations

Scott Teitelbaum, Ben Phalin, Amanda K. Janner, L. R. Solomon, Kent Mathias +4 more

Risk of cardiovascular disease among head and neck cancer survivors: A population-based matched cohort study

Oral Oncology(2024)10.1016/j.oraloncology.2024.107041

N/A

0DataRank · unranked

2 citations

Hilary C. McCrary, Mei Wei, Bayarmaa Mark, Sarah M. Drejet, Richard B. Cannon +8 more

Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti–PD-1 Treatment-Naïve Advanced Melanoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0987

N/A

0DataRank · unranked

5 citations

Mohammed Milhem, Christopher Hoimes, Asim Amin, Cristopher Lao, Robert M. Conry +17 more